Ulcerative colitis.

Slides:



Advertisements
Similar presentations
Medical Management of Ulcerative Colitis
Advertisements

GI Drugs PHC 5409B Dr. T.C. Peterson.
Relapsing and Severe C. difficile Disease Role of Fecal Microbiota Transfer.
Colitis in the Very Young
Management of Inflammatory bowel disease 8/12/10.
Investigation of Diarrhoea IBD IBS Sarah Lean Consultant Gastroenterologist Hillingdon.
Inflammatory Bowel Disease
Treating the Outpatient with Severe IBD: Case Discussions William Tremaine, MD Corey A. Siegel, MD.
Progress in Diagnosing and Treating Clostridium difficile in IBD patients Alan C. Moss MD, FEBG, FACG, AGAF Associate Professor of Medicine Director of.
Antimicrobials and risks for antibiotic-associated diarrhea (AAD) Antibiotic-associated diarrhea 5-30% risk Higher with multiple IV drugs Higher with broad.
Monday AM report
Inflammatory bowel disease/ Irritable bowel syndrome Dr. Syed Md. Basheeruddin Asdaq.
DRUG TREATMENT OF INFLAMMATORY BOWEL DISEASE. Objectives Describe the mechanism of action, pharmacokinetics and adverse effects of drugs in IBD.
Anna Giles – Surgical Registrar POWH
UC. Ulcerative Colitis ( UC ) Ulcerative colitis is an inflammatory bowel disease (IBD) that causes chronic inflammation of the digestive tract It is.
Inflammatory Bowel Disease Treatment. Epidemiology Clinical Laboratory Imaging Pathology Response to treatment IBD.
Inflammatory Bowel Diseases Dr. Nematollah Ahangar Assistant Prof. of Pharmacology.
Ulcerative Colitis Mild-Moderate Distal Colitis Mild-Moderate Extensive Colitis Severe Colitis Criteria for Evaluating the Severity of Ulcerative Colitis.
Case A 25-year-old woman A 4-m history of abdominal pain in the left lower quadrant and bloody diarrhea.
Diagnosis & Management of Ulcerative Colitis. Ulcerative colitis is a World-Wide disease Incidence (new cases): –5 cases per 100,000 –High incidence in.
Inflammatory Bowel Disease (IBD)
By: Leon Richardson Period 2
Case Presentation. Female Patient AB Aged 20 First seen by me in August 2009 Had been diagnosed with Crohn’s Disease in March 2009.
Medical Management of Ulcerative Colitis Conrad Beckett Bradford Royal Infirmary M62 Course March 2006.
Dr. Angus Lee SET 1 General Surgery. Burrill Crohn, an American Gastroenterologist, with his 2 other colleagues first described “Terminal ileitis” in.
Drugs used in inflammatory bowel disease and biological and immune therapy of IBD Prof. Hanan Hagar Pharmacology Department College of Medicine.
Definitions UC Inflammation confined to mucosa Inflammation confined to mucosa Starting in rectum Starting in rectum May involve entire colon May involve.
“Antibiotics and corticosteroids: Indications and approaches”
Dr. Gholam Reza Khatami Ulcerative colitis is a chronic gastrointestinal disease Given modern treatment, medical management is not curative.
Drugs used in inflammatory bowel disease and biological and immune therapy of IBD Prof. Hanan Hagar Pharmacology Unit College of Medicine.
General Principles of Medical and Surgical Management of Inflammatory Bowel Disease Jeraldine S. Orlina Colorectal Conference December 22, 2005.
IBD Patient Update Case Vignettes 12 November 2011.
Inflammatory bowel disease/ Irritable bowel syndrome Dr. Syed Md. Basheeruddin Asdaq.
Chronic inflammatory Bowel Diseases By Prof. Abdulqader Alhaider 1434H.
Drugs used in inflammatory bowel disease and biological and immune therapy of IBD Profs. Alhaider and Hanan Hagar Pharmacology Department College of Medicine.
Clinical Vignette: Medical Grand Rounds Joshua L. Denson MD Internal Medicine PGY2 January 7, 2013 U NITED S TATES D EPARTMENT OF V ETERANS A FFAIRS.
It's Time A 63-year-old woman was admitted because of severe abdominal pain, fatigue and bloody diarrhea.
IBD Cases Stephen B. Hanauer, MD Professor of Medicine Feinberg School of Medicine Medical Director, Digestive Health Center.
Sponsors Crohn’s & Colitis Foundation of America Our Mission: To cure Crohn’s disease and ulcerative colitis, and to improve the quality of life of children.
Chronic inflammatory Bowel Diseases By Prof. Abdulqader Alhaider 1432 H.
Infection International Infection. International Objectives definition predisposing factors pathophysiology clinical features sites of postpartum infection.
ULCERATIVE COLITIS. Ulcerative colitis is an idiopathic chronic inflammatory disease of the colon that follows a course of relapse and remission. In a.
IBD Treatment: The Basics
Drugs used in inflammatory bowel disease and biological and immune therapy of IBD Prof. Hanan Hagar Pharmacology Unit College of Medicine.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Improving outcome of Inflammatory Bowel Disease in children Dinesh Pashankar, MD Pediatric Gastroenterologist Director- Pediatric IBD program Yale University.
Inflammatory bowel disease (IBD)
Ulcerative colitis.
Inflammatory Bowel Disease (IBD)
Prof. Hanan Hagar Pharmacology Unit College of Medicine
Melanie Jaeger T4 Tutoring.
ULCERATIVE COLITIS Dr.Mohammadzadeh.
Inflammatory bowel disease
Inflammatory Bowel Disease
objectives Define inflammatory bowel disease.
IBD vs IBS diagnosis and management
Onderzoek met geneesmiddelen
Ulcerative colitis (UC)
Inflammatory bowel disease: aminosalicylates
Goals of Therapy for Patients With UC
Complicated Cases in Ulcerative Colitis
Management of Clostridium Difficile Infection
Patient Case: KC. Optimizing Treatment of Mild to Moderate Ulcerative Colitis: A Case-Based Perspective.
TREATMENT OF ULCERATIVE COLITIS
Lecture 12 Gastrointestinal Disorders Inflammatory Bowel Disease
“Drugs used in IBD and biological and immune therapy of IBD ”
Prof. Hanan Hagar Pharmacology Unit College of Medicine
Ulcerative Colitis Definition
Presentation transcript:

Ulcerative colitis

Essentials of diagnosis: Bloody diarrhea Lower abdominal cramps & fecal urgency Anemia, low serum albumin Negative stool cultures Sigmoidoscopy is the key to diagnosis

Ulcerative colitis: Assessment of disease severity Mild Moderate Severe Stool frequency/day <4 4-6 >6(mostly bloody) Pulse rate <90 90-100 >100 Hematocrit% Normal 30-40 <30 Weight loss% None 1-10 >10 Temperature(0F) 99-100 ESR (mm/hr) <20 20-30 >30 Albumin (g/dL) 3-3.5 <3

Stomach Jejunum Ileum Colon         Sulfasalazine Olsalazine Meslamine pH sensitive Release Tablets Mesalamine Delayed Release Capsules 5-ASA derivatives in ulcerative colitis: site of absorption of major drugs

Treatment of ulcerative colitis: Proctitis: Mesalamine suppositories, 500mg twice daily, or Hydrocortisone foam, 90mg per rectum daily or Hydrocortisone suppositories, 100mg per rectum daily Proctosigmoiditis: Meslamine enema, 4g per rectum daily, or Hydrocortisone enema, 100mg per rectum daily

Treatment of ulcerative colitis: Extensive colitis: Mild to moderate: Sulfasalazine, 1.5-3g orally twice daily., or Mesalamine tablets (delayed release), 2.4-4.8g/day, or Balsalszide,2.25g three times a day If no response after 2-4 weeks, add prednisone,20-40mg/d (taper by 5mg/week) Severe: Methylprednisolone, 48-60mg IV daily

Distal colitis: Drug of choice meslamine suppository If patients fail to respond: Increase the same topical agent twice daily Combination treatment with a 5-ASA enema at bed-time and a corticosteroid enema or foam in the morning. Combination of a topical agent with oral 5-ASA agent

Distal colitis: Early/ frequent relapse: Maintenance- mesalamine supposositories (500mg/d) -Oral 5-ASA agents

Mild to moderate colitis: 5-ASA derivatives Sulfasalazine 500mg bd (along with folic acid 1mg/d) Mesalamine 1g four times daily Balsalazide 2.25g tid Olsalazine 500mg bd No improvement after 2-3 weeks: Topical steroids 5-ASA enemas Oral steroids

Severe colitis: General: Discontinue oral intake for 24-48hrs. Total parenteral nutrition Correct acid-base deficits,anemia Treat C difficle infection if present.

Severe colitis: Steroids: Methylprednisolone 48-64mg or hydrocortisone 300mg in 4 divided doses or continuous infusion Can try ACTH infusion 120 units/24hr. Cyclosporine IV 2-4mg/kg/d infusion SURGICAL

Fulminant colitis and toxic megacolon: Broad spectrum antibiotics to cover anaerobes & Gram –ve bacteria Surgery to prevent perforation Maintanence of remission: Chronic sulfasalazine, olsalazine, mesalamine.

Refractory disease: Mercaptopurine Azathioprine Transdermal nicotine Infliximab